Twist Bioscience
Focus: Twist Bioscience is a synthetic biology company specializing in synthetic DNA, genes, and libraries for research and therapeutic development across multiple disease areas. The company operates as a mid-cap biotech platform enabling drug discovery and gene therapy development.
Profile data last refreshed 4h ago · AI intelligence enriched 1w ago
Open Jobs
27+6 this month
Growing — net +6 jobs in 30d
16 jobs added vs 10 removed. Steady team buildout.
Should You Work at Twist Bioscience?
AI assessmentTwist is a growth-stage platform biotech suitable for scientists seeking foundational synthetic biology expertise and early-stage upside, but limited financial transparency and clinical pipeline depth create career-risk for those seeking established drug programs or clear near-term catalysts.
Why Work Here
- Platform technology model offers exposure to multiple therapeutic areas (neurology, ophthalmology, oncology, gastroenterology, gene therapy) without single-product risk.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Growing
Jobs increasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Twist Bioscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.